Frédéric Baribaud

机构：Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Belgium) · ORCID：0000-0001-9233-1664

发表论文 132 篇 · 总被引 8731 次 · h-index 45

代表论文

• Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation (2018 · Journal of Allergy and Clinical Immunology · 被引 198)
• Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis (2018 · Gastroenterology · 被引 72)
• Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease (2017 · Nature Medicine · 被引 59)
• Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma (2017 · European Respiratory Journal · 被引 52)
• Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation (2023 · Allergy · 被引 45)
• Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study (2017 · Journal of Allergy and Clinical Immunology · 被引 42)